Publikationen von Prakash Chelladurai
Alle Typen
Zeitschriftenartikel (11)
2025
Zeitschriftenartikel
Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension govern right ventricle remodeling and recovery. NATURE CARDIOVASCULAR RESEARCH 4 (7) (2025)
2023
Zeitschriftenartikel
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension. NATURE CARDIOVASCULAR RESEARCH 2 (10), S. 917 - + (2023)
Zeitschriftenartikel
The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization. CANCER RESEARCH 83 (14), S. 2345 - 2357 (2023)
2022
Zeitschriftenartikel
Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension. SCIENCE TRANSLATIONAL MEDICINE 14 (648), eabe5407 (2022)
2021
Zeitschriftenartikel
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL 57 (4), 1901192 (2021)
Zeitschriftenartikel
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy. BRITISH JOURNAL OF PHARMACOLOGY 178 (1), S. 54 - 71 (2021)
2020
Zeitschriftenartikel
Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension. SCIENTIFIC REPORTS 10 (1), 12864 (2020)
2016
Zeitschriftenartikel
Vascular Cell-Specific Genome-Wide Profiling Of Epigenetic Landscape Reveals Gene Regulatory Signatures In Human Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 193 (2016)
Zeitschriftenartikel
Vascular Cell-Specific Genome-Wide Profiling Of Epigenetic Landscape Reveals Gene Regulatory Signatures In Human Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 193 (2016)
Zeitschriftenartikel
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives. EUROPEAN RESPIRATORY REVIEW 25 (140), S. 135 - 140 (2016)
Zeitschriftenartikel
Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series). Pulmonary Circulation 6 (4), S. 448 - 464 (2016)